Bethesda-based American Capital sells Wis. drug maker

American Capital Ltd., of Bethesda, a publicly traded private equity and global asset management firm focused on middle-market investments, said it sold its portfolio company, SPL Acquisition Corp., of Wenaukee, Wis., to a Chinese company, Shenzhen Hepalink Pharmaceutical Co. Ltd., for $291 million in debt and equity proceeds.

Leave a Reply

Your email address will not be published. Required fields are marked *